Abstract

Background: To develop and validate a magnetic resonance imaging (MRI)-derived radiomic signature (RS) for the prediction of 1-year locoregional failure (LRF) in patients with hypopharyngeal squamous cell carcinoma (HPSCC) who received organ preservation therapy (OPT). Methods: A total of 800 MRI-based features of pretreatment tumors were obtained from 116 patients with HPSCC who received OPT from two independent cohorts. The least absolute shrinkage and selection operator regression model were used to select the features used to develop the RS. Harrell's C-index and corrected C-index were used to evaluate the discriminative ability of RS. The Youden index was used to select the optimal cut-point for risk category. Findings: The RS yielded a 1000 times bootstrapping corrected C-index of 0.803 and 0.782 in the experimental (n = 82) and validation cohorts (n = 34), respectively. With respect to the subgroup of patients with stage III/IV and cT4 disease, the RS also showed good predictive performance with corrected C-indices of 0.760 and 0.754, respectively. The dichotomized risk category using an RS of 0.0326 as the cut-off value yielded a 1-year LRF predictive accuracy of 79.27%, 79.41%, 76.74%, and 71.15% in the experimental, validation, stage III/IV, and cT4a cohorts, respectively. The low-risk group was associated with a significantly better progression-free laryngectomy-free and overall survival outcome in two independent institutions, stage III/IV, and cT4a cohorts. Interpretation: The RS-based model provides a novel and convenient approach for the prediction of the 1-year LRF and survival outcome in patients with HPSCC who received OPT. Funding: This study was supported by the following research grants MOST 107-2314-B-002-217-MY3 from the Ministry of Science and Technology, Taiwan, NTUH 108-S4143 from National Taiwan University Hospital, Taiwan, and NTUHYL 106.S006 from the National Taiwan University Hospital Yun-Lin Branch. Declaration of Interest: All authors of this paper declare no conflict of interest. Ethical Approval: The Research Ethical Committee of the Chang-Gung Memorial Hospital and the National Taiwan University Hospital approved the retrospective study protocol.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call